Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
PEN:NYSE
Penumbra Inc
$325.99
-0.61%
(-1.99) 1D
$325.99
0.00% (0.00)
After hours
Closed: Apr 28, 4:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PEN...
Open
$328.48
High
$328.73
Low
$325.76
Mkt. cap
12.82B
Avg. vol.
566.10K
Volume
344.76K
P/E ratio
72.09
52-wk high
$362.41
52-wk low
$221.26
EPS
$4.52
Beta
0.84
Shares outstanding
39.32M
No. of employees
5K
News stories
From sources across the web
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend. Wikipedia
About Penumbra Inc
CEOAdam Elsesser
Employees4.7K
Founded2004
Headquarters-
SectorMedical device
Websitepenumbrainc.com
Next call in 8 days
Wed, May 6, 4:30 PM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (1.06 est.)USD
Revenue / Estimate
-/ (372.04M est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
324.14M
339.46M
354.68M
385.38M
Cost of goods sold
108.26M
115.44M
114.27M
123.26M
Cost of revenue
108.26M
115.44M
114.27M
123.26M
Research and development expenses
22.08M
23.22M
22.68M
21.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
153.46M
159.96M
168.90M
181.10M
Operating expense
175.53M
183.18M
191.58M
202.90M
Total operating expenses
283.79M
298.63M
305.85M
326.15M
Operating income
40.35M
40.83M
48.84M
59.23M
Other non operating income
-
-
-
593.00K
EBT including unusual items
43.86M
45.31M
52.32M
63.63M
EBT excluding unusual items
43.86M
45.31M
52.32M
63.63M
Income tax expense
4.64M
40.00K
6.47M
16.29M
Effective tax rate
10.57%
0.09%
12.37%
25.60%
Other operating expenses
-
-
-
-
Net income
39.22M
45.27M
45.85M
47.34M
Net profit margin
12.10%
13.34%
12.93%
12.28%
Earnings per share
0.83
0.86
0.97
1.18
Interest and investment income
3.38M
3.99M
4.36M
4.56M
Interest expense
-322.00K
-319.00K
-338.00K
-333.00K
Net interest expenses
3.06M
3.67M
4.02M
4.23M
Depreciation and amortization charges
-
-
-
-
EBITDA
45.36M
46.34M
51.33M
63.49M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer